Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
AVASA logo — company profile

AVASA

Founded 2018 24 employees Seed Total: $1.55M Medical Devices

General Information

Company Name AVASA
Founded Year 2018
Employees 24
Industries Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with AVASA. To contact AVASA, visit avasa.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AVASA compare?

A PDF of AVASA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AVASA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AVASA

AVASA is a venture-backed medical device company founded in 2018 with a mission to simplify microsurgery. They have developed the AVASA Coupler, an implantable device designed to help microsurgeons connect microvascular arteries and veins safer, simpler, and 80% faster than the current standard of care. The company recently received a $1.55M Seed Round investment on 13 September 2023. The investors in this round include Brisbane Angels, NZ Growth Capital Partners, Bridgewest Group, Pacific Channel, Cure Kids Ventures, Uniservices, and Booster. Focusing on the Medical Devices industry, AVASA has attracted notable support and funding from a diverse group of investors, positioning them for growth and impact in the healthcare sector.

Business keywords: medical device, surgical procedures, implantable devices, microsurgery, innovation, start-up, New Zealand, venture backed

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.55M 7
Brisbane Angels NZ Growth Capital Partners Bridgewest Group
Brisbane Angels, NZ Growth Capital Partners +5
13 Sep 2023

AVASA Alternatives & Competitors

View All Alternatives
AVASA vs
Lydus Medical
Lydus Medical Israel

Automated micro anastomosis for ultra-small vessels

Seed
7 employees
Health Care, Medical Devices
AVASA vs
Innovein
Innovein United States

NOTICE: Please visit our website for any current job opportunities. Innovein has not and will not...

Venture round
1 employees
Health Care, Medical Devices
AVASA vs
Vivasure Medical Ltd.
Vivasure Medical Ltd. Ireland

PerQseal® - Minimal Vascular Complications – Simply Delivered

Series D
44 employees
Biopharma, Health Care
View all alternatives

FAQ About AVASA

AVASA is a venture backed medical device company on a mission to simplify microsurgery by delivering the AVASA Coupler – an implantable device designed to help microsurgeons connect microvascular arteries and veins safer, simpler, and 80% faster than the current standard of care.
AVASA was founded in 2018.
AVASA operates in Medical Devices. Its work centres on medical device, surgical procedures, implantable devices and microsurgery.
AVASA has approximately 24 employees.
AVASA has completed 1 funding round, raising a total of $1.55M. The latest funding stage is Seed.
Top alternatives and competitors to AVASA include Lydus Medical, Innovein, Vivasure Medical Ltd., Cameron Health, Rhaeos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AVASA and Lydus Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AVASA, https://bouncewatch.com/company/avasa, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout